You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CEFPROZIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cefprozil, and when can generic versions of Cefprozil launch?

Cefprozil is a drug marketed by Apotex Inc, Aurobindo Pharma, Chartwell Rx, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, Sandoz, Alkem Labs Ltd, Teva, and Wockhardt. and is included in sixteen NDAs.

The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cefprozil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cefprozil

A generic version of CEFPROZIL was approved as cefprozil by CHARTWELL RX on November 14th, 2005.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CEFPROZIL?
  • What are the global sales for CEFPROZIL?
  • What is Average Wholesale Price for CEFPROZIL?
Drug patent expirations by year for CEFPROZIL
Drug Prices for CEFPROZIL

See drug prices for CEFPROZIL

Drug Sales Revenue Trends for CEFPROZIL

See drug sales revenues for CEFPROZIL

Recent Clinical Trials for CEFPROZIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Affiliated Hospital of Qingdao UniversityPhase 1
James Graham Brown Cancer CenterEarly Phase 1
Julio RamirezEarly Phase 1

See all CEFPROZIL clinical trials

US Patents and Regulatory Information for CEFPROZIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt CEFPROZIL cefprozil TABLET;ORAL 065428-002 Jun 14, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ranbaxy Labs Ltd CEFPROZIL cefprozil TABLET;ORAL 065198-002 Dec 13, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva CEFPROZIL cefprozil TABLET;ORAL 065208-001 Dec 6, 2005 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.